Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

Protective strategies against perinatal brain injury represent a major challenge for modern neonatology. Erythropoietin (Epo) enhances endogenous mechanisms of repair and angiogenesis. In order to analyse the newest evidence on the role of Epo in prematurity, hypoxic ischemic encephalopathy (HIE) an...

詳細記述

書誌詳細

出版年:	Antioxidants
主要な著者:	Serafina Perrone, Chiara Lembo, Federica Gironi, Chiara Petrolini, Tiziana Catalucci, Giulia Corbo, Giuseppe Buonocore, Eloisa Gitto, Susanna Maria Roberta Esposito
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-03-01
主題:	erythropoietin newborn neuroprotection preterm Hypoxic Ischemic Encephalopathy perinatal stroke
オンライン･アクセス:	https://www.mdpi.com/2076-3921/11/4/652